Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-001648
Filing Date
2014-05-20
Accepted
2014-05-20 15:13:13
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 556214
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 17149
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 17050
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 10357
  Complete submission text file 0001493152-14-001648.txt   4280701

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE trgm-20140331.xml EX-101.INS 552693
6 XBRL SCHEMA FILE trgm-20140331.xsd EX-101.SCH 43378
7 XBRL CALCULATION FILE trgm-20140331_cal.xml EX-101.CAL 49514
8 XBRL DEFINITION FILE trgm-20140331_def.xml EX-101.DEF 117123
9 XBRL LABEL FILE trgm-20140331_lab.xml EX-101.LAB 304706
10 XBRL PRESENTATION FILE trgm-20140331_pre.xml EX-101.PRE 214133
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-Q | Act: 34 | File No.: 000-53071 | Film No.: 14857668
SIC: 2834 Pharmaceutical Preparations